Puerto Madryn

Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing

Retrieved on: 
Wednesday, April 24, 2024

Following close of the MSLP Loan Purchase, Venus Concept and Madryn entered into a Loan and Security Agreement (“Madryn Loan Agreement”), dated April 23, 2024, pursuant to which Madryn provides an aggregate principal amount of up to $5.0 million in debt financing to the Company to support near-term liquidity requirements.

Key Points: 
  • Following close of the MSLP Loan Purchase, Venus Concept and Madryn entered into a Loan and Security Agreement (“Madryn Loan Agreement”), dated April 23, 2024, pursuant to which Madryn provides an aggregate principal amount of up to $5.0 million in debt financing to the Company to support near-term liquidity requirements.
  • A principal amount of $2.0 million net of transaction fees was drawn by the Company at the close of the transaction.
  • As of December 31, 2023, the MSLP Loan had an outstanding balance of $51.3 million.
  • Madryn’s purchase of our outstanding senior debt facility and extension of bridge financing provides critical support in this process.

Calibrate Names Rob MacNaughton as New Chief Executive Officer

Retrieved on: 
Friday, February 9, 2024

Calibrate, the leading clinician-guided and value-based obesity treatment program, today announced Rob MacNaughton as the company’s new Chief Executive Officer.

Key Points: 
  • Calibrate, the leading clinician-guided and value-based obesity treatment program, today announced Rob MacNaughton as the company’s new Chief Executive Officer.
  • MacNaughton brings a wealth of experience and leadership to his role at Calibrate as the company embarks on its enterprise-first growth phase, with OptumRx as a strategic partner.
  • As a nationally recognized healthcare technology executive leader, MacNaughton has a proven track record launching new verticals, overseeing product development, and scaling operations at healthcare companies.
  • “There has never been a more opportune time for this company,” added Calibrate co-President and Chief Commercial Officer Scott Honken.

Madryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company’s Proposed Merger with Standard BioTools

Retrieved on: 
Tuesday, December 12, 2023

Additionally, Madryn announced it has filed a preliminary proxy statement with the Securities and Exchange Commission (“SEC”) in order to solicit proxies in opposition to the Merger.

Key Points: 
  • Additionally, Madryn announced it has filed a preliminary proxy statement with the Securities and Exchange Commission (“SEC”) in order to solicit proxies in opposition to the Merger.
  • That is why we intend to vote AGAINST the Merger at the upcoming Special Meeting on January 4, 2024.
  • Additionally, we have taken steps to soon be in a position to actively solicit your votes AGAINST the Merger.
  • In the meantime, we urge you to reach out to SomaLogic to express your views on the Merger.

GREENBROOK TMS RAISES US$4.0 MILLION IN DEBT FINANCING

Retrieved on: 
Friday, December 15, 2023

As part of the Amendment, the Company secured an additional US$4,015,548.22 in senior secured term loans from Madryn under the Credit Facility (the "New Loan").

Key Points: 
  • As part of the Amendment, the Company secured an additional US$4,015,548.22 in senior secured term loans from Madryn under the Credit Facility (the "New Loan").
  • After giving effect to the New Loan, the Company has an aggregate amount of approximately US$76 million outstanding under the Credit Facility (collectively, the "Loans").
  • The proceeds of the New Loan is expected to be used by the Company to fund certain debt service obligations of the Company and for general corporate and working capital purposes.
  • The Company is also currently considering additional near-term financing options to address its future liquidity needs.